Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 1986 Feb;31(2 Suppl):55S-62S.
doi: 10.1007/BF01309324.

Comparative inhibition of coffee-induced gastric acid secretion employing misoprostol and cimetidine

Clinical Trial

Comparative inhibition of coffee-induced gastric acid secretion employing misoprostol and cimetidine

P R Salmon et al. Dig Dis Sci. 1986 Feb.

Erratum in

  • Dig Dis Sci 1987 Oct;32(10):1214

Abstract

Six healthy subjects (three men, three women) were studied to compare the effects of misoprostol and cimetidine on coffee-induced gastric secretion. Gastric secretion was measured after a 12-hr fast according to the Hobsley method, employing phenolsulfonphthalein (PSP) as a marker. Each subject was studied on three occasions separated by at least one week: as control, basal gastric secretion was measured followed by sample collection after oral placebo and then coffee; basal gastric secretion was measured followed by sample collection after 200 micrograms of misoprostol and then coffee; basal gastric secretion was measured followed by 300 mg [corrected] of cimetidine and then coffee. The order of treatment was randomized. Basal gastric secretion collection, sample collection, and the administration of coffee were carefully standardized. Titratable acidity; acid output; and sodium, potassium, chloride, and PSP concentrations were measured in each sample to assess hydrogen ion secretion, pyloric losses, and duodenogastric reflux. Mathematical corrections were available for the last. Results confirmed that coffee is associated with a marked rise in titratable acidity, peak acid output (PAO), and volume with a modest fall in mean gastric pH. Both misoprostol and cimetidine lowered titratable acidity, compared with placebo (P = 0.03). Mean PAO was reduced by both misoprostol and cimetidine in a similar manner, and there was a significant difference between the three treatment groups (P = 0.02). These findings document and confirm the antisecretory effect of a single oral dose (200 micrograms) of misoprostol on gastric secretion.

PubMed Disclaimer

References

    1. N Engl J Med. 1975 Oct 30;293(18):897-9 - PubMed
    1. Scand J Gastroenterol. 1971;6(5):453-7 - PubMed
    1. Am J Dig Dis. 1972 Nov;17(11):993-6 - PubMed
    1. Gastroenterology. 1976 Nov;71(5):738-42 - PubMed

LinkOut - more resources